THBC/CGF for Alveolar Bone Regeneration: A Real-World Study
NCT: NCT07779421 · RECRUITING
Brief Summary
This study aims to combine real-world research with relevant bone repair materials and techniques to improve alveolar bone resorption in extraction sockets following impacted wisdom tooth removal, while achieving effective bone preservation or promoting bone regeneration. All eligible cases within specified parameters will be included in the clinical study scope. Based on real-world clinical data, we will proactively collect postoperative clinical examination findings and imaging data. Statistical analysis will be performed on clinical outcomes and follow-up data from patients undergoing mandibular impacted M3 extraction. The study aims to clarify the therapeutic efficacy of the thermosensitive hydroxyethylchitosan-loaded concentrated growth factor group in repairing mesial bone defects of M2s following M3 extraction.
Frequently Asked Questions
What is THBC/CGF for Alveolar Bone Regeneration: A Real-World Study?
THBC/CGF for Alveolar Bone Regeneration: A Real-World Study is a clinical trial registered under NCT07779421. Current status: RECRUITING.
What is the status of NCT07779421?
The current status of NCT07779421 (THBC/CGF for Alveolar Bone Regeneration: A Real-World Study) is: RECRUITING.
When did THBC/CGF for Alveolar Bone Regeneration: A Real-World Study start?
THBC/CGF for Alveolar Bone Regeneration: A Real-World Study started on 2024-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.